1. Home
  2. SLND vs MREO Comparison

SLND vs MREO Comparison

Compare SLND & MREO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Southland Holdings Inc.

SLND

Southland Holdings Inc.

HOLD

Current Price

$0.87

Market Cap

67.6M

Sector

Industrials

ML Signal

HOLD

Logo Mereo BioPharma Group plc

MREO

Mereo BioPharma Group plc

HOLD

Current Price

$0.34

Market Cap

67.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SLND
MREO
Founded
1900
2015
Country
United States
United Kingdom
Employees
2100
N/A
Industry
Military/Government/Technical
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
67.6M
67.5M
IPO Year
N/A
2017

Fundamental Metrics

Financial Performance
Metric
SLND
MREO
Price
$0.87
$0.34
Analyst Decision
Hold
Buy
Analyst Count
1
5
Target Price
$4.00
$3.13
AVG Volume (30 Days)
132.2K
1.5M
Earning Date
03-26-2026
03-19-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
16.67
EPS
N/A
N/A
Revenue
N/A
$500,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$6,363.05
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.65
$0.20
52 Week High
$5.34
$2.94

Technical Indicators

Market Signals
Indicator
SLND
MREO
Relative Strength Index (RSI) 34.64 34.82
Support Level N/A $0.20
Resistance Level $4.57 $0.42
Average True Range (ATR) 0.12 0.03
MACD 0.04 0.01
Stochastic Oscillator 41.22 22.62

Price Performance

Historical Comparison
SLND
MREO

About SLND Southland Holdings Inc.

Southland Holdings Inc is an infrastructure construction company in North America. The company's infrastructure projects range from water conveyance systems and tunnels to long-span bridges and vertical structures. The company operates in two distinct segments: Civil and Transportation. The civil segment operates throughout North America and specializes in services that include the design and construction of water pipelines, pump stations, lift stations, water and wastewater treatment plants, concrete and structural steel, outfall, and tunneling. The transportation segment operates throughout North America and specializes in services that include the design and construction of bridges, roadways, marine, dredging, ship terminals and piers, and specialty structures and facilities.

About MREO Mereo BioPharma Group plc

Mereo BioPharma Group PLC is a United Kingdom (U.K.) based biopharmaceutical company focused on the development of therapeutics for rare diseases. The company has developed a portfolio of late-stage clinical product candidates, and its two rare disease product candidates are setrusumab for the treatment of osteogenesis imperfecta (OI) and alvelestat primarily for the treatment of severe alpha-1 antitrypsin deficiency-associated lung disease (AATD-LD).

Share on Social Networks: